Other factors for assessment of patient’s bleeding risk include
- Prior bleeding within 3 mo
- Prior bleeding with a similar type of procedure
- Platelet abnormality (platelet count lower than 20,000 per microliter for low-risk and lower than 50,000 per microliter for high-risk procedures).
- INR above therapeutic range at the time of the procedure
- Prior bleeding with bridging therapy
- Mechanical mitral heart valve
- Active cancer
Reference:
Patel, Indravadan J., et al. “Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe.” Journal of vascular and interventional radiology: JVIR (2019). https://www.ncbi.nlm.nih.gov/pubmed/31229333
Suggested Link:
https://articl.net/resource/interventional-radiology-medications